Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab

Otto Metzger Filho, Giuseppe Viale, Shayna Stein, Lorenzo Trippa, Denise A Yardley, Ingrid A Mayer, Vandana G Abramson, Carlos L Arteaga, Laura M Spring, Adrienne G Waks, Eileen Wrabel, Michelle K DeMeo, Aditya Bardia, Patrizia Dell'Orto, Leila Russo, Tari A King, Kornelia Polyak, Franziska Michor, Eric P Winer, Ian E Krop

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Impact of HER2 Heterogeneity on Treatment Response of Early-Stage HER2-Positive Breast Cancer: Phase II Neoadjuvant Clinical Trial of T-DM1 Combined with Pertuzumab'. Together they form a unique fingerprint.

Medicine & Life Sciences